There is hope for Q2 Guizhou Bailing and United Xin Pharmaceutical conduct clinical research on anti-new coronary pneumonia drugs Oral hypoglycemic drugs dominate in Beijing, Shanghai and Guangzhou.
INR:8935. football club in jaipur The DPP-4 hypoglycemic drug landscape is turbulent: the first generic version of linagliptin is approved and vildaglipti ...
ipl format New progress in HEC's hypoglycemic drug! "Ronggliflozin pyroglutamic acid" starts Phase III clinical trial WuXi Biologics included in the Hang Seng Index! Net profit in the first half of ...
family horse racing Who is behind Henlius' IPO? Inventory丨TOP 10 popular varieties that have been “accepted/passed” in consistency evaluation New class of hypoglycemic drug imeglimin shows strong ...
INR:9929. pro kabaddi 2021 auction Terazosin may reduce risk of Parkinson's disease Hunan pharmaceutical companies won over 8 billion yuan in oral hypogl ...